Consistent with results obtained in MEFs as shown in Figure 3C, silencing MYO1B increased nuclear PTEN with a concomitant decrease in cytoplasmic PTEN in melanoma cells (Figures 6F and 6G). The gene discussed is PTEN; the disease is melanoma.